Coventry Health Care, Inc. (CVH) is Investigated by Faruqi & Faruqi, LLP for Potential Breaches of Fiduciary Duties by Its Board of Directors

NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Coventry Health Care, Inc. (“Coventry” or the “Company”) (NYSE: CVH) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to Aetna Inc. (“Aetna”) (NYSE: AET) in a cash-and-stock deal valued at approximately $7.3 billion. Under the terms of the proposed transaction, Coventry stockholders will receive $27.30 in cash and 0.3885 Aetna common shares for each Coventry share they own. The agreement values the proposed consideration at approximately $42.08 per share, based on the closing price of Aetna common shares on Friday, August 17, 2012.